Sleep physiology features from digital trackers predict next-day physical fatigue in healthy adults with moderate accuracy
This exploratory study found that sleep tracker-derived features, particularly respiratory rate and REM sleep duration, could predict next-day physical fatigue in healthy adults with an AUC of 0.75. Predictive performance was lower in neurodegenerative disease (AUC=0.62) and immune-mediated inflammatory disease cohorts, indicating limited generalizability to chronic disease populations.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Sleep physiology features from digital trackers predict next-day physical fatigue in healthy adults with moderate accuracy The current body of evidence comprises 1 study. EvidenceHub rates the overall confidence at 34/100 (low).
The Claim
Sleep physiology features from digital trackers predict next-day physical fatigue in healthy adults with moderate accuracy
This conclusion is most relevant to: 134 participants (42 healthy adults, 39 with neurodegenerative diseases, 53 with immune-mediated inflammatory diseases) across four European centres.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Exploring the feasibility of modeling next-day fatigue and sleepiness using digital sleep tracker data in neurodegenerative and immune-mediated inflammatory diseases. (Frontiers in digital health, 2026) —
How It Works
The proposed biological pathway:
- ▸Sleep trackers measure physiological and sleep-architecture features (e.g., respiratory rate, REM duration, REM latency, deep sleep)
- ▸Machine learning models use these features to classify next-day fatigue and sleepiness levels
- ▸Respiratory rate and REM sleep duration are key predictors in healthy adults
- ▸Result: Models show preliminary discriminative capacity for next-day physical fatigue in healthy adults
Who Might Benefit
Evidence fit by population:
- ▸134 participants (42 healthy adults, 39 with neurodegenerative diseases, 53 with immune-mediated inflammatory diseases) across four European centres
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Outcome binarisation using a global threshold may conflate between-person disease-group differences with within-person symptom variation
- ▸Predictive performance in chronic disease cohorts remains limited, underscoring need for larger, multimodal studies
- ▸Exploratory analysis with small sample sizes per subgroup
Frequently Asked Questions
What sleep features were most predictive of next-day fatigue?▼
Respiratory rate and REM sleep duration were the main drivers for predicting physical fatigue in healthy adults, while REM latency and deep sleep were key features in the neurodegenerative disease group.
How accurate were the sleep trackers in predicting fatigue?▼
The best model achieved an AUC of 0.75 for next-day physical fatigue in healthy adults, indicating moderate discriminative capacity. Performance was lower in disease groups, with AUCs around 0.62-0.66.
Can these findings be applied to people with chronic diseases?▼
Not directly. The predictive performance was limited in neurodegenerative and immune-mediated inflammatory disease cohorts, suggesting that disease-specific models and larger studies are needed.
What type of sleep trackers were used in this study?▼
Three devices were used: BedSensor (a bed-mounted sensor), ZKONE (a wearable), and DREEM 2 (a headband), covering both consumer- and research-grade trackers.
References
- 1.Zhai B, Chen L, Ma X, Pinaud C, Chatterjee M, Kortelainen JM, Rehman RZU, Ahmaniemi T, Avey S, Guan Y, Macrae V, Hinchliffe C, Del Din S, Manyakov NV, Göder R, Romijnders R, Maetzler W, Reilmann R, Aufenberg S, Schubert R, van der Woude CJ, Zhang D, Ng WF. “Exploring the feasibility of modeling next-day fatigue and sleepiness using digital sleep tracker data in neurodegenerative and immune-mediated inflammatory diseases..” Frontiers in digital health, 2026. PMID: 42388291 DOI: 10.3389/fdgth.2026.1752629